Elisabeth Quoix, et al.
16th World Conference on Lung Cancer. September 2015, Denver, Colorado
Download the poster here
Poster Presentation
TG4010 Immunotherapy plus Chemotherapy as First Line Treatment of Advanced NSCLC: Phase 2b Results.
Par alcyon|2019-07-02T17:02:34+02:00septembre 10th, 2015|Publication, TG4010|Commentaires fermés sur TG4010 Immunotherapy plus Chemotherapy as First Line Treatment of Advanced NSCLC: Phase 2b Results.
À propos de l'auteur : alcyon
Articles similaires
- Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
- BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
- Transgene communique sur l’essai clinique de combinaison de TG4010 avec la chimiothérapie et nivolumab dans le traitement du cancer du poumon non à petites cellules
Transgene communique sur l’essai clinique de combinaison de TG4010 avec la chimiothérapie et nivolumab dans le traitement du cancer du poumon non à petites cellules